Progress in the development of specific immunotherapies for house dust mite allergies

References

• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160
   PubMed Web of Science ®Google Scholar
• Van Bronswijk JE, Sinha RN. Pyroglyphid mites (Acari) and house dust mite allergy. J Allergy 1971;47:31-52
   PubMedGoogle Scholar
• Thomas WR. Geography of house dust mite allergens. Asian Pac J Allergy Immunol 2010;28:211-24
   PubMed Web of Science ®Google Scholar
• Hales BJ, Martin AC, Pearce LJ, et al. IgE and IgG anti-house dust mite specificities in allergic disease. J Allergy Clin Immunol 2006;118:361-7
   PubMed Web of Science ®Google Scholar
• Weghofer M, Thomas WR, Kronqvist M, et al. Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest 2008;38:959-65
   PubMed Web of Science ®Google Scholar
• Barber D, Arias J, Boquete M, et al. Analysis of mite allergic patients in a diverse territory by improved diagnostic tools. Clin Exp Allergy 2012;42:1129-38
   PubMed Web of Science ®Google Scholar
• Voorhorst R, Spieksma F, Varekamp H, et al. The house dust mite (Dermatophagoides pteronyssinus) and the allergens it produces. Identity with the house dust allergen. J Allergy 1967;39:323-39
   Google Scholar
• Miyazawa H, Sakaguchi M, Inouye S, et al. Seasonal changes in mite allergen (Der pI and Der pII) concentrations in Japanese homes. Ann Allergy Asthma Immunol 1996;76:170-4
   PubMed Web of Science ®Google Scholar
• Moscato G, Perfeti L, Galdi E, et al. Levels of house-dust-mite allergen in homes of nonallergic people in Pavia, Italy. Allergy 2000;55:873-8
   PubMed Web of Science ®Google Scholar
• Ngelhart S, Bieber T, Exner M. House dust mite allergen levels in German day-care centers. Int J Hyg Environ Health 2002;205:453-7
   PubMed Web of Science ®Google Scholar
• Sidenius KE, Hallas TE, Poulsen LK, Mosbech H. House dust mites and their allergens in Danish mattresses - results from a population based study. Ann Agric Environ Med 2002;9:33-9
   PubMed Web of Science ®Google Scholar
• Raffan E, Lawrence H, Henderson T, et al. Prevalence of the group 1 Dermatophagoides allergens Der p 1 and Der f 1 in homes with no dogs, healthy dogs and Dermatophagoides-sensitized atopic dogs in Liverpool. Vet Dermatol 2005;16:253-60
   PubMed Web of Science ®Google Scholar
• Macchiaverni P, Rekima A, Turfkruyer M, et al. Respiratory allergens in human milk: potential impact on susceptibility to allergic asthma. Allergy 2014;69:395-8
   PubMed Web of Science ®Google Scholar
• Schram-Bijkerk D, Doekes G, Boeve M, et al. Nonlinear relations between house dust mite allergen levels and mite sensitization in farm and non-farm children. Allergy 2006;61:640-7
   PubMed Web of Science ®Google Scholar
• Zock JP, Heinrich J, Jarvis D, et al. Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II. J Allergy Clin Immunol 2006;118:682-90
   PubMed Web of Science ®Google Scholar
• Smith AM, Benjamin DC, Hozic N, et al. The molecular basis of antigenic cross reactivity between group 2 mite allergens. J Allergy Clin Immunol 2001;107:977-84
   PubMed Web of Science ®Google Scholar
• Park JW, Kim KS, Jin HS, et al. Der p 2 isoallergens have different allergenicity and quantification with 2-site ELISA using monoclonal antibodies is influenced by the isoallergens. Clin Exp Allergy 2002;32:1042-7
   PubMed Web of Science ®Google Scholar
• Hales BJ, Thomas WR. T cell sensitization to epitopes from the house dust mites Dermatophagoides pteronyssinus and Euroglyphus maynei. Clin Exp Allergy 1997;27:266-875
   Web of Science ®Google Scholar
• Hales BJ, Shen HD, Thomas WR. Cross reactivity of T cell responses to Dermotophagoides pteronyssinus and D. farinae: studies with group 1 and 7 allergens. Clin Exp Allergy 2000;30:927-33
   PubMed Web of Science ®Google Scholar
• Wambre E, Bonvalet M, Bodo VB, et al. Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4+ T cell responses. Clin Exp Allergy 2010;41:192-203
   PubMed Web of Science ®Google Scholar
• Gregory LG, Lloyd CM. Orchestrating house dust mite-associated allergy in the lung. Trends Immunol 2011;32:402-11
   PubMed Web of Science ®Google Scholar
• Jacquet A. Innate immune responses in house dust mite allergy. IRSN Allergy 2013;2013:1-18. 735031 Hindoui publishing Ed
   Google Scholar
• Hammad H, Lambrecht B. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008;8:193-204
   PubMed Web of Science ®Google Scholar
• Hammad H, Chieppa M, Perros F, et al. House dust mite allergen induces asthma via TLR4 triggering of airway structural cells. Nat Med 2009;15:410-16
   PubMed Web of Science ®Google Scholar
• Valerio RC, Murray P, Arlian LG, Slater JE. Bacterial 16S ribosomal DNA in house dust mite cultures. J Allergy Clin Immunol 2006;118:1296-300
   Google Scholar
• Da Silva CA, Pochard P, Lee CG, Elias JA. Chitin particles are multifaceted immune adjuvants. Am J Respir Crit Care Med 2010;182:1482-91
   PubMed Web of Science ®Google Scholar
• Thomas WR, Smith W, Hales BJ. The allergenic specificities of the house dust mite. Chang Gung Med J 2004;27:563-9
   PubMedGoogle Scholar
• Thomas WR, Hales BJ, Smith WA. House dust mite allergens in asthma and allergy. Trends Mol Med 2010;16:321-8
   PubMed Web of Science ®Google Scholar
• Bessot JC, Pouli G. Mite allergens: an overview. Eur Annu Allergy Clin Immunol 2011;43:141-56
   PubMedGoogle Scholar
• WHO/IUIS allergen nomenclature database. Available from: www.allergen.org
   Google Scholar
• Batard T, Nony E, Chabre H, et al. Molecular and functional characterization of natural allergen extracts. Proceedings of the 13th PEI meeting (14-17 September 2011). 2013. pp 54-6
   Google Scholar
• Zhang YY, Sun X, Liu ZG. Morphology and Three-dimensional reconstruction of the digestive system of dermatophagoides farinae. Int Arch Allergy Immunol 2008;146:219-26
   PubMed Web of Science ®Google Scholar
• Batard T, Hrabina A, Bi XZ, et al. Production and proteomic characterization of pharmaceutical grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccines. Int Arch Allergy Immunol 2006;140:295-305
   PubMed Web of Science ®Google Scholar
• Weghofer M, Grote M, Resch Y, et al. Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol 2013;190:3059-67
   PubMed Web of Science ®Google Scholar
• Hales BJ, Elliot CE, Chai LY, et al. Quantification of IgE binding to the Chitinase and Chitinase-like house dust mite allergens Der p 15 and Der p 18 compared to the major and mid range allergens. Int Arch Allergy Immunol 2013;160:233-40
   PubMed Web of Science ®Google Scholar
• Kidon M, Chin CW, Kong LW, et al. Mite component-specific IgE repertoire and phenotypes of allergic disease in childhood: the tropical perspective. Pediatr Allergy Immunol 2011;22:202-10
   PubMed Web of Science ®Google Scholar
• Chapman MD, Wunschmann S, Pomes A. Proteases as Th2 adjuvants. Curr Allergy Asthma Rep 2007;7:363-7
   PubMed Web of Science ®Google Scholar
• Roelandt T, Heughebaert C, Hachem JP. Proteolytically active allergens cause barrier breakdown. J Invest Dermatol 2008;128:1878-80
   PubMed Web of Science ®Google Scholar
• Trompette A, Divanovic S, Visintin A, et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009;457:585-8
   PubMed Web of Science ®Google Scholar
• Mueller GA, Edwards LL, Aloor JJ, et al. The structure of the dust mite allergen Der p 7 reveals similarities to innate immune proteins. J Allergy Clin Immunol 2010;125:909-17
   PubMed Web of Science ®Google Scholar
• Epton MJ, Dilworth RJ, Smith W, Thomas WR. Sensitization to the lipid-binding apolipophorin allergen Der p 14 and the peptide Mag-1. Int Arch Allergy Immunol 2001;124:57-60
   PubMed Web of Science ®Google Scholar
• Smith WA, Hales BJ, Jarnicki AG, Thomas WR. Allergens of wild house dust mites: environmental Der p 1 and Der p 2 sequence polymorphisms. J Allergy Clin Immunol 2001;107:985-92
   PubMed Web of Science ®Google Scholar
• Ayuso R, Reese G, Leong-Kee S, et al. Molecular basis of arthropod cross-reactivity: igE-binding cross-reactive epitopes of shrimp, house dust mite and cockroach tropomyosins. Int Arch Allergy Immunol 2002;129:38-48
   PubMed Web of Science ®Google Scholar
• Van Ree R, Antonicelli L, Akkerdaas JH, et al. Possible induction of food allergy during mite immunotherapy. Allergy 1996;51:108-13
   PubMed Web of Science ®Google Scholar
• Pajno GB, La Grutta S, Barberio G, et al. Harmful effect of immunotherapy in children with combined snail and mite allergy. J Allergy Clin Immunol 2002;109:627-9
   PubMed Web of Science ®Google Scholar
• Tourdot S, Airouche S, Berjont N, et al. Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation. Clin Exp Allergy 2011;41:1784-92
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 2007;119:881-91
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Casale T, et al. Sub-lingual immunotherapy: World Allergy Organization position paper. Allergy 2009;64:1-59
   PubMed Web of Science ®Google Scholar
• Cox L, Jacobsen L. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol 2009;103:451-60
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Bachert C, Bousquet PJ, et al. GA2LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy 2010;65:1525-30
   PubMed Web of Science ®Google Scholar
• Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011;127(Suppl):S1-55
   PubMed Web of Science ®Google Scholar
• Akdis M, Akdis C. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 2014;133:621-31
   PubMed Web of Science ®Google Scholar
• Moingeon P. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician. J Allergy Clin Immunol Pract 2013;1:228-41
   PubMed Web of Science ®Google Scholar
• Frati F, Incorvaia C, David M, et al. Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy. Drug Design Dev Ther 2012;6:117-23
   PubMed Web of Science ®Google Scholar
• Moingeon P, Batard T, Nony E, et al. Quality control of House Dust Mite extracts for allergen immunotherapy. Int Arch Allergy Immunol 2013;161:285-6
   PubMed Web of Science ®Google Scholar
• Calderon MA, Simons FE, Malling HJ, et al. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy 2012;67:302-11
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Epstein T, Murphy-Berendts K, Liss GM. Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study. Ann Allergy Asthma Immunol 2010;104:530-5
   PubMed Web of Science ®Google Scholar
• James LK, Shamji MH, Walker SM, et al. Long term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 2011;127:509-16
   PubMed Web of Science ®Google Scholar
• Vanbervliet B, Tourdot S, Rouzaire P, et al. SLIT prevents the development of Eczema in percutaneous allergen-sensitized mice. J Invest Dermatol 2012;132:244-6
   PubMed Web of Science ®Google Scholar
• Fernandez-Caldas E. Towards a more complete standardization of mite allergen extracts. Int Arch Allergy Immunol 2013;160:1-3
   PubMed Web of Science ®Google Scholar
• Brunetto B, Tinghino R, Braschi MC, et al. Characterization and comparison of commercially available mite extracts for in vivo diagnosis. Allergy 2010;65:184-90
   PubMed Web of Science ®Google Scholar
• Casset A, Mari A, Purohit A, et al. Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol 2012;159:253-62
   PubMed Web of Science ®Google Scholar
• Moingeon P. Sublingual immunotherapy: from biological extracts to recombinant allergens. Allergy 2006;61(S81):15-19
   PubMed Web of Science ®Google Scholar
• Valenta R, Niespodziana K, Focke-Tejkl M, et al. Recombinant allergens: what does the future hold? J Allergy Clin Immunol 2011;127:860-4
   PubMed Web of Science ®Google Scholar
• Cromwell O, Hafner D, Nandy A. Recombinant allergens for specific immunotherapy. J Allergy Clin Immunol 2011;127:865-72
   PubMed Web of Science ®Google Scholar
• Campbell JD, Buckland KF, Mc Millan SJ, et al. peptide immunotherapy in allergic asthma generaltes IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med 2009;206:1535-47
   PubMed Web of Science ®Google Scholar
• Yang L, Kajiura H, Suzuki K, et al. Generation of a transgenic rice seed-based edible vaccine against house dust mite allergy. Biochem Biophys Res Commun 2008;365:334-9
   PubMed Web of Science ®Google Scholar
• Walgraffe D, Matteotti C, el Bakkoury M, et al. A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines. J Allergy Clin Immunol 2009;123:1150-6
   PubMed Web of Science ®Google Scholar
• Burtin D, Chabre H, Didierlaurent A, et al. Production of native and modified recombinant Der p 1 forms in tobacco plants. Clin Exp Allergy 2009;39:760-70
   PubMed Web of Science ®Google Scholar
• Bussières L, Bordas V, Bulder I, et al. Fusion proteins assembling Der p 1 and Der p 2 major allergens from Dermatophagoides pteronyssinus. Int Arch Allergy Immunol 2010;153:141-51
   PubMed Web of Science ®Google Scholar
• Bordas V, Bussières L, Airouche S, et al. Expression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapy. Int Arch Allergy Immunol 2012;158:157-67
   PubMed Web of Science ®Google Scholar
• Marth K, Focke-Teijkl M, Lupinek C, et al. Allergen peptides, recombinant allergens and hypoallergens for allergen-specific immunotherapy. Curr Treat Options Allergy 2014;1:91-106
   PubMedGoogle Scholar
• Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trials using the cochrane collaboration method. Allergy 2006;61:1162-72
   PubMed Web of Science ®Google Scholar
• Penagos M, Passalacqua G, Compalati E, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008;133:599-609
   PubMed Web of Science ®Google Scholar
• Compalati E, Passalacqua G, Bonini M and Canonca GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009;64:1570-9
   PubMed Web of Science ®Google Scholar
• Lin SY, Erekosima N, Kim JM, et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA 2013;309:1278-88
   PubMed Web of Science ®Google Scholar
• Abramson MJ, Puy RM, Weiner JM. Injection immunotherapy for asthma. Cochrane Data base Syst Rev 2010;8:CD001186
   PubMed Web of Science ®Google Scholar
• Calderon MA, Casale TB, Nelson HS, Demoly P. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol 2013;132:1322-36
   PubMed Web of Science ®Google Scholar
• Ameal A, Vega-Chicote JM, Fernandez S, et al. Double blind and placebo-controlled study to assess efficacy and safety of a modified extract of Dermatophagoides pteronyssinus in allergic asthma. Allergy 2005;60:1178-83
   PubMed Web of Science ®Google Scholar
• Garcia-Robaina JC, de la Torre F, Sanchez I, et al. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study. J Allergy Clin Immunol 2006;118:1026-32
   PubMed Web of Science ®Google Scholar
• Bergmann KC, Demoly P, Worm M, et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. J Allergy Clin Immunol 2014;133:1608-14
   PubMed Web of Science ®Google Scholar
• Mosbech H, Deckelmann R, de Blay F, et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double blind, placebo-controlled trial. J Allergy Clin Immunol 2014; In Press
   PubMed Web of Science ®Google Scholar
• Larché M, Hickey P, Hebert J, Hafner R. Safety and tolerability of escalating doses of house dust mite-peptide antigen desensitization (HDM-PAD). abstract J Allergy Clin Immunol 2013;131:AB37
   Web of Science ®Google Scholar
• Kunding TM, Senti G, Schnetzler G, et al. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol 2006;117:1470-6
   PubMed Web of Science ®Google Scholar
• Chabre H, Gouyon B, Adam A, et al. Molecular variability of group 1 and 5 gras pollen allergens between Pooideae species: implications for specific immunotherapy. Clin Exp Allergy 2010;40:505-19
   PubMed Web of Science ®Google Scholar
• Moingeon P. The specificities of allergen recognition by CD4+ T lymphocytes at the epitopic level. Clin Exp Allergy 2014;44:898-900
   PubMed Web of Science ®Google Scholar
• Archila LD, DeLong JH, Wambre E, et al. Grass-specific CD4+ T cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy. Clin Exp Allergy 2014;44:986-98
   PubMed Web of Science ®Google Scholar
• Wambre E, Delong JH, James EA, et al. Specific immunotherapy modifies allergen-specific CD4+ T cell responses in an epitope-dependent manner. J Allergy Clin Immunol 2013;133:872-9
   PubMed Web of Science ®Google Scholar